Rentokil(US:RTO) Prnewswire·2025-01-09 22:58Core Viewpoint - A class action has been filed against Rentokil Initial PLC for allegedly misleading investors regarding the integration of Terminix, which has led to significant operational challenges and lower-than-expected revenue growth in North America [2][3]. Group 1: Allegations and Integration Issues - The complaint alleges that Rentokil did not disclose various issues during the integration of Terminix, including disruption in early pilots, ongoing execution challenges, and the fact that Rentokil and Terminix remained separate businesses [2]. - The failure to effectively integrate Terminix has negatively impacted Rentokil's business operations, particularly its organic revenue growth in North America [2]. Group 2: Impact on Stock Price - Following the announcement of the integration challenges on September 11, 2024, Rentokil's American Depository Shares (ADSs) fell by $6.65, or over 21%, from $31.60 to $24.95 [3]. Group 3: Class Action Participation - Investors who purchased Rentokil ADSs between December 1, 2023, and September 10, 2024, may be eligible to participate in the class action, with a deadline to apply as lead plaintiff set for January 27, 2025 [4].